abstract |
Provided by the present invention are substituted piperidine compounds having orexin type II receptor agonistic activity. The compound represented by formula (I), wherein each symbol is as described in the specification, or a salt thereof, has orexin type II receptor agonistic activity, and is used as a prophylactic or therapeutic agent for narcolepsy. |